SELECTIVE PHARMACOLOGIC ACTIVATION OF THE P53-DEPENDENT PATHWAY AS A THERAPEUTIC STRATEGY FOR HEMATOLOGIC MALIGNANCIES

STUHMER, T., & BARGOU, R.C.. (2006). SELECTIVE PHARMACOLOGIC ACTIVATION OF THE P53-DEPENDENT PATHWAY AS A THERAPEUTIC STRATEGY FOR HEMATOLOGIC MALIGNANCIES. CELL CYCLE, 5(-), 39-42. SID. https://sid.ir/paper/676123/en

STUHMER T., BARGOU R.C.. SELECTIVE PHARMACOLOGIC ACTIVATION OF THE P53-DEPENDENT PATHWAY AS A THERAPEUTIC STRATEGY FOR HEMATOLOGIC MALIGNANCIES. CELL CYCLE[Internet]. 2006;5(-):39-42. Available from: https://sid.ir/paper/676123/en

T. STUHMER, and R.C. BARGOU, “SELECTIVE PHARMACOLOGIC ACTIVATION OF THE P53-DEPENDENT PATHWAY AS A THERAPEUTIC STRATEGY FOR HEMATOLOGIC MALIGNANCIES,” CELL CYCLE, vol. 5, no. -, pp. 39–42, 2006, [Online]. Available: https://sid.ir/paper/676123/en